scholarly journals Evaluation of transduction efficiency in macrophage colony-stimulating factor differentiated human macrophages using HIV-1 based lentiviral vectors

2011 ◽  
Vol 11 (1) ◽  
Author(s):  
Francisco J Leyva ◽  
Joshua J Anzinger ◽  
J Philip McCoy ◽  
Howard S Kruth
2000 ◽  
Vol 164 (9) ◽  
pp. 4955-4960 ◽  
Author(s):  
Joseph Kutza ◽  
Lynne Crim ◽  
Steven Feldman ◽  
Mark P. Hayes ◽  
Marion Gruber ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Jani Lappalainen ◽  
Nicolas Yeung ◽  
Su D. Nguyen ◽  
Matti Jauhiainen ◽  
Petri T. Kovanen ◽  
...  

AbstractIn atherosclerotic lesions, blood-derived monocytes differentiate into distinct macrophage subpopulations, and further into cholesterol-filled foam cells under a complex milieu of cytokines, which also contains macrophage-colony stimulating factor (M-CSF) and granulocyte–macrophage-colony stimulating factor (GM-CSF). Here we generated human macrophages in the presence of either M-CSF or GM-CSF to obtain M-MØ and GM-MØ, respectively. The macrophages were converted into cholesterol-loaded foam cells by incubating them with acetyl-LDL, and their atheroinflammatory gene expression profiles were then assessed. Compared with GM-MØ, the M-MØ expressed higher levels of CD36, SRA1, and ACAT1, and also exhibited a greater ability to take up acetyl-LDL, esterify cholesterol, and become converted to foam cells. M-MØ foam cells expressed higher levels of ABCA1 and ABCG1, and, correspondingly, exhibited higher rates of cholesterol efflux to apoA-I and HDL2. Cholesterol loading of M-MØ strongly suppressed the high baseline expression of CCL2, whereas in GM-MØ the low baseline expression CCL2 remained unchanged during cholesterol loading. The expression of TNFA, IL1B, and CXCL8 were reduced in LPS-activated macrophage foam cells of either subtype. In summary, cholesterol loading converged the CSF-dependent expression of key genes related to intracellular cholesterol balance and inflammation. These findings suggest that transformation of CSF-polarized macrophages into foam cells may reduce their atheroinflammatory potential in atherogenesis.


AIDS ◽  
1992 ◽  
Vol 6 (12) ◽  
pp. 1550
Author(s):  
A. Lafeuillade ◽  
C. Tamalet ◽  
P. Pellegrino ◽  
C. Tourres ◽  
C. Vignoli ◽  
...  

Apmis ◽  
2017 ◽  
Vol 125 (6) ◽  
pp. 596-603 ◽  
Author(s):  
Mehdi Mahdavi ◽  
Amir Hossein Tajik ◽  
Massoumeh Ebtekar ◽  
Roghieh Rahimi ◽  
Mohammad Mehdi Adibzadeh ◽  
...  

AIDS ◽  
2000 ◽  
Vol 14 (12) ◽  
pp. 1739-1748 ◽  
Author(s):  
Katherine Kedzierska ◽  
Anne Maerz ◽  
Tammra Warby ◽  
Anthony Jaworowski ◽  
HiuTat Chan ◽  
...  

Blood ◽  
1990 ◽  
Vol 75 (6) ◽  
pp. 1215-1219 ◽  
Author(s):  
SM Hammer ◽  
JM Gillis ◽  
P Pinkston ◽  
RM Rose

Abstract The alveolar macrophage (AM), as a representative human tissue macrophage, was used in an in vitro system to examine the anti-human immunodeficiency virus type-1 (HIV-1) activity of zidovudine (AZT) and granulocyte-macrophage colony-stimulating factor (GM-CSF). AMs were infected with the IIIB strain of HIV-1 and exposed to AZT (1 mumol/L), GM-CSF (30 U/mL), a combination of AZT (1 mumol/L)/GM-CSF (30 U/mL), or medium control. At 10 or 20 days post-infection, phytohemagglutinin (PHA)-stimulated peripheral blood mononuclear leukocytes (PBMLs) were added to the AM cultures as stimulated target cells. AZT effectively suppressed HIV replication and prevented transfer/amplification in target PBMLs as long as the drug was maintained in the medium. GM-CSF neither suppressed nor augmented HIV replication. The combination of AZT/GM-CSF was comparable with AZT alone in suppressing both the initial infection of AMs and the transfer to target PBMLs as long as the agents were maintained in the cultures. However, when the drugs were removed at the same time that PHA-stimulated PBMLs were added to the culture, the combination of AZT/GM-CSF was found to be more effective than AZT alone in preventing the transfer/amplification of HIV in the target lymphocytes. These results suggest that (1) AZT is effective in inhibiting HIV-1 infection in mononuclear phagocytes; (2) GM-CSF neither inhibits nor augments the replication of the IIIB strain of HIV in human AMs; and (3) the combination of AZT and GM-CSF may have an enhanced anti-HIV-1 activity compared with AZT alone. Clinical trials with the two agents in combination appear warranted.


Sign in / Sign up

Export Citation Format

Share Document